Horizon Therapeutics PLC (NASDAQ:HZNP)
| 99.59 Delayed Data As of May 26 |  -0.29 / -0.29%Today’s Change | 57.84 Today|||52-Week Range 113.83 | -12.49% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | 26.0M | 89.9M | -32.9M | -5.1M | |
| Depreciation | 69.2M | 69.0M | 58.9M | 59.1M | ||
| Total Other Cash Flow | 38.1M | 28.2M | 39.4M | 50.1M | ||
| Funds From Operations | 136.8M | 121.0M | 66.9M | 101.3M | ||
| Funds From/For Other Operating Expenses | 51.9M | 12.3M | 10.8M | 10.0M | ||
| Net Cash Flow - Operating Activities | 84.9M | 108.7M | 56.2M | 91.3M | ||
| Investing | Capital Expenditures | -119.0K | -3.9M | -1.8M | -5.0M | |
| Fixed Asset Disposal | 9.4M | 35.0M | 0.00 | 0.00 | ||
| Other Investing - Sources | 0.00 | 0.00 | 0.00 | 6.0M | ||
| Net Cash Flow Investing | 9.3M | 31.1M | -1.8M | 991.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 818.0M | 0.00 | 517.4M | ||
| Long Term Debt Reduction | -1.0K | -818.0M | -300.0M | -776.3M | ||
| Net Proceeds Stock Sale | 6.1M | 11.1M | 337.8M | 6.5M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 3.7M | 1.6M | 17.2M | 7.2M | ||
| Net Cash Flow - Financing | 2.4M | 9.5M | 20.6M | -259.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 315.0K | -692.0K | -518.0K | 576.0K | |
| Net Change In Cash | 96.5M | 149.4M | 74.9M | -167.4M | ||
